argenx SE (ARGX:NASDAQ) closed at $960.04 on November 13, 2026, down 2.17% on the day. The stock trades 10.5% below its 52-week high of $1,072.75 and 45.1% above its 52-week low of $661.85. Over the past year, it gained 5.7%. argenx SE is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since November 13, 2025, ARGX closed higher on 123 days (49%). Its best day was August 17, 2026 (+16.04%) and its worst was October 8, 2026 (-11.83%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases.
Find more stocks like ARGX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.